会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Benzofuran derivatives useful in treating diabetic complications
    • 可用于治疗糖尿病并发症的苯并呋喃衍生物
    • US4666931A
    • 1987-05-19
    • US814135
    • 1985-12-27
    • Yoshitaka OhishiMichiko NagaharaNorio KajikawaMotoyuki YajimaKatsumi NogimoriShigeki Kurokawa
    • Yoshitaka OhishiMichiko NagaharaNorio KajikawaMotoyuki YajimaKatsumi NogimoriShigeki Kurokawa
    • C07D337/00A61K31/34A61K31/343A61K31/36A61K31/415A61P3/08A61P3/10A61P7/02C07D307/79C07D307/80C07D307/82C07D307/85C07D307/86C07D405/04C07D493/04
    • C07D307/82C07D307/80C07D307/85C07D307/86C07D405/04C07D493/04
    • A benzofuran derivative having the general formula (I): ##STR1## wherein R.sup.1 is hydrogen atom, a benzyl group, unsubstituted or substituted with a halogen atom or an alkyloxy group, or an alkyl group having 1 to 3 carbon atoms, R.sup.2 is hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R.sup.3 is acetyl group, ethyl group, carboxyl group or 4-methyl-2,5-dioxoimidazolidine-4-yl group, R.sup.4 is hydrogen atom, hydroxyl group, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 9 carbon atoms, carboxymethoxy group, nitro group, acetoamino group, a benzylozy group unsubstituted or substituted with a halogen atom, nitro group or an alkyloxy group or a group having the formula: --OR.sup.6, wherein R.sup.6 is an alkenyl group having 2 to 4 carbon atoms or an alkyl group having 2 to 3 carbon atoms having a halogen atom, cyano group or oxo group, R.sup.5 is hydrogen atom or methylenedioxy group together with R.sup.4 group, n is 1 or 2, and the unsubstituted or substituted N-carboxymethylsulfamoyl group, R.sup.4 and R.sup.5 are attached at 3-position, 4-position, 5-position, 6-position or 7-position of the benzofuran ring, or a nontoxic salt thereof, process for preparing the same and a pharmaceutical composition containing the same.The compounds of the present invention have powerful aldose reductase inhibiting activity, platelet aggregation inhibiting activity and arachidonic acid metabolism inhibiting activity and are useful for a remedy for treatment of diabetic complications.
    • 具有通式(I)的苯并呋喃衍生物:其中R1是氢原子,未被取代或被卤素原子或烷氧基取代的苄基或具有1至3个碳原子的烷基的苄基, R2是氢原子或碳原子数1〜3的烷基,R3是乙酰基,乙基,羧基或4-甲基-2,5-二氧代咪唑烷-4-基,R4是氢原子,羟基, 具有1至6个碳原子的烷基,具有1至9个碳原子的烷氧基,羧甲氧基,硝基,乙酰氨基,未被取代或被卤素原子取代的苄氧基,硝基或烷氧基或具有 式:-OR6,其中R6是具有2至4个碳原子的烯基或具有2至3个碳原子的具有卤素原子的烷基,氰基或氧代基,R5是氢原子或亚甲二氧基以及R4基团, n为1或2,未取代或取代的N-羧甲基氨磺酰基 基团,R4和R5连接在苯并呋喃环的3-位,4-位,5-位,6-位或7-位上,或其无毒盐,其制备方法和含有它们的药物组合物 。 本发明化合物具有强大的醛糖还原酶抑制活性,血小板聚集抑制活性和花生四烯酸代谢抑制活性,可用于治疗糖尿病并发症的治疗方法。